Endo International (Portfolio of Generic Products) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Asset Purch.

  • Financing Rounds
  • 1

Endo International (Portfolio of Generic Products) General Information

Description

Portfolio of 24 drug product applications. The portfolio includes 23 approved and 1 pending drug product application, consists of oral solutions with a few semi-solid products.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Carmel, NY
  • United States
Primary Industry
Buildings and Property
Other Industries
Other Pharmaceuticals and Biotechnology
Acquirer
Corporate Office
  • Carmel, NY
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Endo International (Portfolio of Generic Products) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Endo International (Portfolio of Generic Products)‘s full profile, request access.

Request a free trial

Endo International (Portfolio of Generic Products) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Endo International (Portfolio of Generic Products)‘s full profile, request access.

Request a free trial

Endo International (Portfolio of Generic Products) FAQs

  • Where is Endo International (Portfolio of Generic Products) headquartered?

    Endo International (Portfolio of Generic Products) is headquartered in Carmel, NY.

  • What industry is Endo International (Portfolio of Generic Products) in?

    Endo International (Portfolio of Generic Products)’s primary industry is Buildings and Property.

  • Is Endo International (Portfolio of Generic Products) a private or public company?

    Endo International (Portfolio of Generic Products) is a Private company.

  • What is the current valuation of Endo International (Portfolio of Generic Products)?

    The current valuation of Endo International (Portfolio of Generic Products) is .

  • What is Endo International (Portfolio of Generic Products)’s current revenue?

    The current revenue for Endo International (Portfolio of Generic Products) is .

  • Who are Endo International (Portfolio of Generic Products)’s investors?

    Endo International has invested in Endo International (Portfolio of Generic Products).

  • When was Endo International (Portfolio of Generic Products) acquired?

    Endo International (Portfolio of Generic Products) was acquired on 07-May-2018.

  • Who acquired Endo International (Portfolio of Generic Products)?

    Endo International (Portfolio of Generic Products) was acquired by Lannett.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process